PubMed

Phase III study of standard combination versus rotating regimen of induction chemotherapy in patients with hormone insensitive metastatic breast cancer: an Eastern Cooperative Oncology Group Intergroup Study (E3185).

Pandya KJ, Hu P, Osborne CK, Falkson G, Tormey DC; Eastern Cooperative Oncology Group.

Am J Clin Oncol. 2007 Apr;30(2):113-25.PMID: 17414459 [PubMed - indexed for MEDLINE]Related articles

Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction.

Sleeper LA, Ramanathan K, Picard MH, Lejemtel TH, White HD, Dzavik V, Tormey D, Avis NE, Hochman JS; SHOCK Investigators.

J Am Coll Cardiol. 2005 Jul 19;46(2):266-73.PMID: 16022953 [PubMed - indexed for MEDLINE]Related articles

Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry).

Slater J, Selzer F, Dorbala S, Tormey D, Vlachos HA, Wilensky RL, Jacobs AK, Laskey WK, Douglas JS Jr, Williams DO, Kelsey SF.

Am J Cardiol. 2003 Oct 1;92(7):773-8.PMID: 14516874 [PubMed - indexed for MEDLINE]Related articles

N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.

Rajdev L, Yu ZF, Wadler S, Weller E, Kahn SB, Tormey D, Skeel R, Wiernik PH.

Invest New Drugs. 2001;19(3):233-7.PMID: 11561680 [PubMed - indexed for MEDLINE]Related articles

21-day oral etoposide for metastatic breast cancer: a phase II study and review of the literature.

Saphner T, Weller EA, Tormey DC, Pandya KJ, Falkson CI, Stewart J, Robert NJ.

Am J Clin Oncol. 2000 Jun;23(3):258-62. Review.PMID: 10857889 [PubMed - indexed for MEDLINE]Related articles

Comparison of chemotherapy with chemohormonal therapy as first-line therapy for metastatic, hormone-sensitive breast cancer: An Eastern Cooperative Oncology Group study.

Sledge GW Jr, Hu P, Falkson G, Tormey D, Abeloff M.

J Clin Oncol. 2000 Jan;18(2):262-6.PMID: 10637238 [PubMed - indexed for MEDLINE]Related articles

Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group.

Recht A, Gray R, Davidson NE, Fowble BL, Solin LJ, Cummings FJ, Falkson G, Falkson HC, Taylor SG 4th, Tormey DC.

J Clin Oncol. 1999 Jun;17(6):1689-700.PMID: 10561205 [PubMed - indexed for MEDLINE]Related articles

Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study.

Mansour EG, Gray R, Shatila AH, Tormey DC, Cooper MR, Osborne CK, Falkson G.

J Clin Oncol. 1998 Nov;16(11):3486-92.PMID: 9817265 [PubMed - indexed for MEDLINE]Related articles

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.

Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J, Sischy B.

Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):269-76.PMID: 9788404 [PubMed - indexed for MEDLINE]Related articles

Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment.

Falkson G, Gelman RS, Pandya KJ, Osborne CK, Tormey D, Cummings FJ, Sledge GW, Abeloff MD.

J Clin Oncol. 1998 May;16(5):1669-76.PMID: 9586877 [PubMed - indexed for MEDLINE]Related articles

Induction chemotherapy of dibromodulcitol, Adriamycin, vincristine, tamoxifen, and Halotestin with methotrexate in metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1181).

Chang AY, Putt M, Pandya KJ, Harris J, Gelman R, Tormey DC, Falkson G.

Am J Clin Oncol. 1998 Feb;21(1):99-104.PMID: 9499270 [PubMed - indexed for MEDLINE]Related articles

The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.

Olson JE, Neuberg D, Pandya KJ, Richter MP, Solin LJ, Gilchrist KW, Tormey DC, Veeder M, Falkson G.

Cancer. 1997 Mar 15;79(6):1138-49.PMID: 9070491 [PubMed - indexed for MEDLINE]Related articlesFree article

Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.

Tormey DC, Gray R, Falkson HC.

J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33.PMID: 8961972 [PubMed - indexed for MEDLINE]Related articlesFree article

Annual hazard rates of recurrence for breast cancer after primary therapy.

Saphner T, Tormey DC, Gray R.

J Clin Oncol. 1996 Oct;14(10):2738-46.PMID: 8874335 [PubMed - indexed for MEDLINE]Related articles

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.

Hansen RM, Ryan L, Anderson T, Krzywda B, Quebbeman E, Benson A 3rd, Haller DG, Tormey DC.

J Natl Cancer Inst. 1996 May 15;88(10):668-74.PMID: 8627643 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).

Cobau CD, Declercq K, Neuberg D, Ingle JN, Tormey DC.

Cancer. 1996 Feb 1;77(3):483-9.PMID: 8630955 [PubMed - indexed for MEDLINE]Related articles

Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group study.

Gertz MA, Kalish LA, Kyle RA, Hahn RG, Tormey DC, Oken MM.

Am J Clin Oncol. 1995 Dec;18(6):475-80.PMID: 8526187 [PubMed - indexed for MEDLINE]Related articles

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, et al.

J Clin Oncol. 1995 Dec;13(12):2936-43.PMID: 8523058 [PubMed - indexed for MEDLINE]Related articles

Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group study.

Falkson G, Holcroft C, Gelman RS, Tormey DC, Wolter JM, Cummings FJ.

J Clin Oncol. 1995 Jun;13(6):1453-8.PMID: 7751892 [PubMed - indexed for MEDLINE]Related articles

Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.

Budd GT, Green S, O'Bryan RM, Martino S, Abeloff MD, Rinehart JJ, Hahn R, Harris J, Tormey D, O'Sullivan J, et al.

J Clin Oncol. 1995 Apr;13(4):831-9.PMID: 7707108 [PubMed - indexed for MEDLINE]Related articles

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.

Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH, Mailliard JA.

Ann Intern Med. 1995 Mar 1;122(5):321-6.PMID: 7847642 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinoma.

Witte RS, Leong T, Ernstoff MS, Krigel RL, Oken MM, Harris J, Tormey DC, Trump DL.

Invest New Drugs. 1995;13(3):241-7.PMID: 8729953 [PubMed - indexed for MEDLINE]Related articles

Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.

Cobleigh MA, Berris RF, Bush T, Davidson NE, Robert NJ, Sparano JA, Tormey DC, Wood WC.

JAMA. 1994 Aug 17;272(7):540-5. No abstract available. Erratum in: JAMA 1995 Feb 1;273(5):378. PMID: 8046809 [PubMed - indexed for MEDLINE]Related articles

Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer.

Bennett JM, Troxel AB, Gelman R, Falkson G, Coccia-Portugal MD, Dreicer R, Tormey DC, Rushing D.

J Clin Oncol. 1994 Apr;12(4):874-5. No abstract available. PMID: 8151329 [PubMed - indexed for MEDLINE]Related articles

Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen.

Gale KE, Andersen JW, Tormey DC, Mansour EG, Davis TE, Horton J, Wolter JM, Smith TJ, Cummings FJ.

Cancer. 1994 Jan 15;73(2):354-61.PMID: 8293400 [PubMed - indexed for MEDLINE]Related articles

Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.

Gilchrist KW, Gray R, Fowble B, Tormey DC, Taylor SG 4th.

J Clin Oncol. 1993 Oct;11(10):1929-35.PMID: 8410120 [PubMed - indexed for MEDLINE]Related articles

High DNA content and prognosis in lymph node positive breast cancer. A case control study by the University of Leiden and ECOG. (Eastern Cooperative Oncology Group).

Gilchrist KW, Gray R, van Driel-Kulker AM, Mesker WE, Ploem-Zaaijer JJ, Ploem JS, Taylor SG, Tormey DC.

Breast Cancer Res Treat. 1993 Oct;28(1):1-8.PMID: 8123866 [PubMed - indexed for MEDLINE]Related articles

Phase II study of goserelin for patients with postmenopausal metastatic breast cancer.

Saphner T, Troxel AB, Tormey DC, Neuberg D, Robert NJ, Pandya KJ, Edmonson JH, Rosenbluth RJ, Abeloff MD.

J Clin Oncol. 1993 Aug;11(8):1529-35.PMID: 8336191 [PubMed - indexed for MEDLINE]Related articles

Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.

Tormey DC, Gray R, Falkson HC, Gilchrist K, Abeloff MD, Falkson G.

Recent Results Cancer Res. 1993;127:185-96. No abstract available. PMID: 8502815 [PubMed - indexed for MEDLINE]Related articles

Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.

Cummings FJ, Gray R, Tormey DC, Davis TE, Volk H, Harris J, Falkson G, Bennett JM.

J Clin Oncol. 1993 Jan;11(1):29-35.PMID: 8418238 [PubMed - indexed for MEDLINE]Related articles

Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial.

Tormey DC, Gray R, Abeloff MD, Roseman DL, Gilchrist KW, Barylak EJ, Stott P, Falkson G.

J Clin Oncol. 1992 Dec;10(12):1848-56.PMID: 1453199 [PubMed - indexed for MEDLINE]Related articles

Phase II trials of interferons-alpha and -beta in advanced sarcomas.

Borden EC, Kim K, Ryan L, Blum RH, Shiraki M, Tormey DC, Comis RL, Hahn RG, Parkinson DR.

J Interferon Res. 1992 Dec;12(6):455-8.PMID: 1289413 [PubMed - indexed for MEDLINE]Related articles

Patients' reactions to completion of adjuvant breast cancer therapy.

Ward SE, Viergutz G, Tormey D, deMuth J, Paulen A.

Nurs Res. 1992 Nov-Dec;41(6):362-6.PMID: 1437586 [PubMed - indexed for MEDLINE]Related articles

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL.

Hum Pathol. 1992 Sep;23(9):974-9.PMID: 1355464 [PubMed - indexed for MEDLINE]Related articles

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L, et al.

J Clin Oncol. 1992 Apr;10(4):599-605.PMID: 1548522 [PubMed - indexed for MEDLINE]Related articles

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.

Clark GM, Mathieu MC, Owens MA, Dressler LG, Eudey L, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, et al.

J Clin Oncol. 1992 Mar;10(3):428-32.PMID: 1740681 [PubMed - indexed for MEDLINE]Related articles

Influence of estradiol and tamoxifen on susceptibility of human breast cancer cell lines to lysis by lymphokine-activated killer cells.

Albertini MR, Gibson DF, Robinson SP, Howard SP, Tans KJ, Lindstrom MJ, Robinson RR, Tormey DC, Jordan VC, Sondel PM.

J Immunother (1991). 1992 Jan;11(1):30-9.PMID: 1734946 [PubMed - indexed for MEDLINE]Related articles

Chemotherapy versus observation in high-risk node-negative breast cancer patients.

Mansour EG, Eudey L, Tormey DC, Shatila AH, Osborne CK, Gilchrist KW, Cooper MR, Falkson G.

J Natl Cancer Inst Monogr. 1992;(11):97-104.PMID: 1627437 [PubMed - indexed for MEDLINE]Related articles

Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: preliminary analysis of an intergroup study (INT 0076).

Dressler LG, Eudey L, Gray R, Tormey DC, McGuire WL, Gilchrist KW, Clark GM, Osborne CK, Mansour EG, Abeloff MD.

J Natl Cancer Inst Monogr. 1992;(11):167-72.PMID: 1627424 [PubMed - indexed for MEDLINE]Related articles

Continuous-infusion 5-fluorouracil combined with doxorubicin and cyclophosphamide: feasibility study.

Saphner T, Tormey DC, Carey P.

Med Pediatr Oncol. 1992;20(4):321-4.PMID: 1608354 [PubMed - indexed for MEDLINE]Related articles

Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study.

Saphner T, Tormey DC, Albertini M.

Cancer. 1991 Dec 1;68(11):2359-62.PMID: 1933771 [PubMed - indexed for MEDLINE]Related articles

Phase I study of toremifene in patients with advanced cancer.

Hamm JT, Tormey DC, Kohler PC, Haller D, Green M, Shemano I.

J Clin Oncol. 1991 Nov;9(11):2036-41. Erratum in: J Clin Oncol 1992 Apr;10(4):674. PMID: 1834808 [PubMed - indexed for MEDLINE]Related articles

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.

Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC.

J Natl Cancer Inst. 1991 Oct 16;83(20):1488-91.PMID: 1920495 [PubMed - indexed for MEDLINE]Related articles

Preliminary ECOG analysis of treatment failure in primary operable breast cancer patients.

Tormey DC, Gray R, Harrington DP.

Oncology (Williston Park). 1991 Jun;5(6):138-9. No abstract available. PMID: 1831637 [PubMed - indexed for MEDLINE]Related articles

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.

Saphner T, Tormey DC, Gray R.

J Clin Oncol. 1991 Feb;9(2):286-94.PMID: 1988575 [PubMed - indexed for MEDLINE]Related articles

A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer.

Ransom DT, Neuberg D, Loprinzi CL, Tormey DC, Blum RH, Harris JE, Asbury RF, Falkson G.

Am J Clin Oncol. 1991 Feb;14(1):45-8.PMID: 1898999 [PubMed - indexed for MEDLINE]Related articles

Organizing multicenter trials: lessons from the cooperative oncology groups.

Carbone PP, Tormey DC.

Prev Med. 1991 Jan;20(1):162-9.PMID: 2008425 [PubMed - indexed for MEDLINE]Related articles

Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer.

Falkson G, Tormey DC, Carey P, Witte R, Falkson HC.

Eur J Cancer. 1991;27(8):973-7.PMID: 1832906 [PubMed - indexed for MEDLINE]Related articles

Phase II study of lonidamine in patients with metastatic breast cancer. An Eastern Cooperative Oncology Group study.

Robins HI, Neuberg DS, Benson AB 3rd, Pandya KJ, Tormey DC.

Invest New Drugs. 1990 Nov;8(4):397-9.PMID: 2084074 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of carboplatin in soft-tissue sarcoma.

Goldstein D, Cheuvart B, Trump DL, Shiraki M, Comis RL, Tormey DC, Harris JE, Borden EC.

Am J Clin Oncol. 1990 Oct;13(5):420-3.PMID: 2220662 [PubMed - indexed for MEDLINE]Related articles